Veterinary Medicines

CANIGEN CH LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE

Authorised
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
Download as PDF

Product identification

Medicine name:
CANIGEN CH LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE
Active substance:
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine adenovirus 2, strain Manhattan, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain Lederle, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0026372 4/1980
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/11/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/11/2025
Download